For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
As of close of business last night, FibroBiologics Inc’s stock clocked out at $0.4, down -2.24% from its previous closing price of $0.41. In other words, the price has decreased by -$2.24 from its previous closing price. On the day, 0.84 million shares were traded. FBLG stock price reached its highest trading level at $0.4271 during the session, while it also had its lowest trading level at $0.3902.
Ratios:
To gain a deeper understanding of FBLG’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.93 and its Current Ratio is at 0.93. In the meantime, Its Debt-to-Equity ratio is 12.53 whereas as Long-Term Debt/Eq ratio is at 2.42.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on December 12, 2024, initiated with a Buy rating and assigned the stock a target price of $12.
On October 30, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $12.
On September 24, 2024, Maxim Group started tracking the stock assigning a Buy rating and target price of $12.Maxim Group initiated its Buy rating on September 24, 2024, with a $12 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 27 ’25 when Khoja Hamid bought 20,000 shares for $0.84 per share. The transaction valued at 16,800 led to the insider holds 31,250 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FBLG now has a Market Capitalization of 16789168 and an Enterprise Value of 18720168.
Stock Price History:
The Beta on a monthly basis for FBLG is -0.49, which has changed by -0.8687398 over the last 52 weeks, in comparison to a change of 0.13837254 over the same period for the S&P500. Over the past 52 weeks, FBLG has reached a high of $3.89, while it has fallen to a 52-week low of $0.41. The 50-Day Moving Average of the stock is -26.86%, while the 200-Day Moving Average is calculated to be -57.39%.
Shares Statistics:
It appears that FBLG traded 691.83K shares on average per day over the past three months and 1423270 shares per day over the past ten days. A total of 40.86M shares are outstanding, with a floating share count of 30.01M. Insiders hold about 28.35% of the company’s shares, while institutions hold 12.26% stake in the company. Shares short for FBLG as of 1759190400 were 965853 with a Short Ratio of 1.40, compared to 1756425600 on 917549. Therefore, it implies a Short% of Shares Outstanding of 965853 and a Short% of Float of 2.69.
Earnings Estimates
. The current assessment of FibroBiologics Inc (FBLG) involves the perspectives of 2 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is -$0.09, with high estimates of -$0.08 and low estimates of -$0.11.
Analysts are recommending an EPS of between -$0.45 and -$0.48 for the fiscal current year, implying an average EPS of -$0.47. EPS for the following year is -$0.52, with 2.0 analysts recommending between -$0.46 and -$0.59.
